BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,203,246 | -25.2% | 50,031 | -0.7% | 0.00% | – |
| Q2 2023 | $1,608,473 | +3.7% | 50,375 | -0.6% | 0.00% | – |
| Q1 2023 | $1,551,117 | +20.3% | 50,657 | +53.6% | 0.00% | – |
| Q4 2022 | $1,289,496 | -5.8% | 32,971 | +14.7% | 0.00% | – |
| Q3 2022 | $1,369,000 | +39.7% | 28,752 | +13.6% | 0.00% | – |
| Q2 2022 | $980,000 | -23.3% | 25,311 | +13.5% | 0.00% | – |
| Q1 2022 | $1,278,000 | -27.2% | 22,307 | +1.3% | 0.00% | – |
| Q4 2021 | $1,756,000 | -13.5% | 22,030 | -5.6% | 0.00% | -100.0% |
| Q3 2021 | $2,030,000 | -17.3% | 23,335 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $2,456,000 | +200.2% | 19,082 | +86.7% | 0.00% | – |
| Q1 2021 | $818,000 | -94.5% | 10,218 | -94.4% | 0.00% | -100.0% |
| Q4 2020 | $14,909,000 | – | 182,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |